Enzymotec raises $63.5 million in Nasdaq IPO

– The lipid-based products developer held the IPO at $14 per share, below its target of $16-18, but the share price rose 30% on Friday. – – Enzymotec Ltd. (Nasdaq: ENZY) has raised a net More...

Enzymotec go public seeks to raise $75 million

–  The nutritional supplements company plans to issue 4.4 million shares at a price range of $16 to $18. “Globes” was the first to report on the company’s plans to go public earlier More...